Вот что повествует по теме медскейп:
The 2 Ureaplasma biovars, Ureaplasma urealyticum and Ureaplasma parvum, are now designated as separate species. Separation of these species is not possible except via molecular techniques such as polymerase chain reaction (PCR). Therefore, they are now considered together as Ureaplasma species. U parvum is generally the most common species detected in various clinical specimens but U urealyticum is apparently more pathogenic in conditions such as male urethritis. This differential pathogenicity at the species level has not been shown consistently for other disease conditions.
[Ссылки доступны только зарегистрированным пользователям ]
то есть нынешняя практическая медицина не разделяет уреаплазму на (под)виды и не проводит по их принадлежности более или менее патогенна или совсем не патогенна.
кое что из более детального обзора о мико/уреаплазмах (со стр. 6) :
Consequently, management may depend on an understanding of what mycoplasmas might cause, and providing therapy empirically. Nevertheless, the mere presence in small numbers of M. hominis and/or ureaplasma organisms in the lower genital tract would not justify treatment. This may not be the case for M. genitalium, which is potentially of greater pathogenicity.
More appropriate would be to treat, early in pregnancy, symptomatic/asymptomatic BV, in which M. hominisis linked, as are ureaplasmas to a lesser extent, using antibiotics active against a range of micro-organisms, including the latter two.
Mycoplasmas in pregnancy
[Ссылки доступны только зарегистрированным пользователям ]
|